Imagion Biosystems hits key development milestone with initiation of toxicology study

Imagion Biosystems has achieved a key milestone in its progress to first-in-human testing with the commencement of a toxicology safety study of its lead…


Investor Update — Corporate Presentation Visuals

Imagion Biosystems has updated investors by lodging the latest version of its corporate presentation visuals with the Australian Securities Exchange. Content…


New mPEG-coated Nanoparticles Clear Slowly from Blood Circulation

At the April 2017 Annual Meeting of the American Association for Cancer Research, we first reported our long-circulating mPEG-coated PrecisionMRX®…


HER-2 Positive Tumor Detection at Tech Connect World Innovation Conference

This year's Tech Connect World Innovation Conference featured the poster "Superparamagnetic relaxometry (SPMR) for sensitive detection of HER-2 positive tumors…